Publication:
The nitrosated bile acid DNA lesion O<sup>6</sup>-carboxymethylguanine is a substrate for the human DNA repair protein O<sup>6</sup>-methylguanine-DNA methyltransferase

dc.contributor.authorPattama Senthongen_US
dc.contributor.authorChristopher L. Millingtonen_US
dc.contributor.authorOliver J. Wilkinsonen_US
dc.contributor.authorAndrew S. Marriotten_US
dc.contributor.authorAmanda J. Watsonen_US
dc.contributor.authorOnrapak Reamtongen_US
dc.contributor.authorClaire E. Eyersen_US
dc.contributor.authorDavid M. Williamsen_US
dc.contributor.authorGeoffrey P. Margisonen_US
dc.contributor.authorAndrew C. Poveyen_US
dc.contributor.otherUniversity of Manchesteren_US
dc.contributor.otherKrebs Instituteen_US
dc.contributor.otherPaterson Institute for Cancer Researchen_US
dc.contributor.otherManchester Institute of Biotechnologyen_US
dc.contributor.otherInstitute Génétique et Dévelopement de Rennesen_US
dc.contributor.otherUniversity of Sussexen_US
dc.contributor.otherUniversity of Liverpoolen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T04:41:37Z
dc.date.available2018-10-19T04:41:37Z
dc.date.issued2013-03-01en_US
dc.description.abstractThe consumption of red meat is a risk factor in human colorectal cancer (CRC). One hypothesis is that red meat facilitates the nitrosation of bile acid conjugates and amino acids, which rapidly convert to DNA-damaging carcinogens. Indeed, the toxic and mutagenic DNA adduct O6-carboxymethylguanine (O6-CMG) is frequently present in human DNA, increases in abundance in people with high levels of dietary red meat and may therefore be a causative factor in CRC. Previous reports suggested that O6-CMG is not a substrate for the human version of the DNA damage reversal protein O6-methylguanine-DNA methyltransferase (MGMT), which protects against the genotoxic effects of other O6-alkylguanine lesions by removing alkyl groups from the O6-position. We now show that synthetic oligodeoxyribonucleotides containing the known MGMT substrate O6-methylguanine (O6-MeG) or O6-CMG effectively inactivate MGMT in vitro (IC50 0.93 and 1.8 nM, respectively). Inactivation involves the removal of the O6-alkyl group and its transfer to the active-site cysteine residue of MGMT. O6-CMG is therefore an MGMT substrate, and hence MGMT is likely to be a protective factor in CRC under conditions where O6-CMG is a potential causative agent. © The Author(s) 2013.en_US
dc.identifier.citationNucleic Acids Research. Vol.41, No.5 (2013), 3047-3055en_US
dc.identifier.doi10.1093/nar/gks1476en_US
dc.identifier.issn13624962en_US
dc.identifier.issn03051048en_US
dc.identifier.other2-s2.0-84876378991en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/31363
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84876378991&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleThe nitrosated bile acid DNA lesion O<sup>6</sup>-carboxymethylguanine is a substrate for the human DNA repair protein O<sup>6</sup>-methylguanine-DNA methyltransferaseen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84876378991&origin=inwarden_US

Files

Collections